|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Provider assessment of adherence to HIV antiretroviral therapy显示文摘 | Bangsberg DR Hecht FM Clague H | 2001 | J Acquir Immune Defic Syndr2001，26，： | 1 |
| 2 | Non-adherence tohighly active antiretroviral therapy predicts progression toAIDS显示文摘 | Bangsberg DR Perry S Charlebois ED | 2001 | AIDS2001，15，9： | 1 |
| 3 | Expanding directly observed therapy:tuberculosis to human immunodeficiency virus显示文摘 | Bangsberg DR Mundy LM Tulsky JP | 2001 | Am J Med2001，110，： | 1 |
| 4 | Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital显示文摘 | LG WINSTON DR BANGSBERG | 2002 | Am J Infect Control2002，30，： | 1 |
| 5 | Expanding access toHIV antiretroviral therapy among marginalized populations in thedeveloped world显示文摘 | Wood E Montaner JS Bangsberg DR | 2003 | AIDS2003，17，： | 1 |
| 6 | Adherence to protease inhibitors,HIV-1viral load,and development of drug resistance in an in-digent population显示文摘 | Bangsberg DR Hecht FM Charlebois ED | 2000 | AIDS2000，14，4： | 1 |
| 7 | Adherence to protease inhibitors, HIV-1 viral load, and development of drugresistance in an indigent population 显示文摘 | Bangsberg DR Heeht FM Charlebois ED | 2000 | AIDS2000，14，： | 1 |
| 8 | Adherence to protease inhibitors, HIV-1 viral load, and development of drug re- sistance in an indigent population显示文摘 | Bangsberg DR Hecht FM Charlebois ED | 2000 | AIDS2000，14，4： | 1 |
| 9 | Adherence to HAART:a systematic review of developed and developing nation patient-reported barriers and facilitators显示文摘 | Mills EJ Nachega JB Bangsberg DR | 2006 | PLo S Med2006，3，11： | 1 |
| 10 | Modeling the impact of modified directly observed antiretroviral yherapy on HIV suppression and resistance,disease progression,and death显示文摘 | Bangsberg DR Porco TC Kagay C | 2004 | Clinical Infectious Diseases2004，38，： | 1 |
| 11 | Adherence to protease inhibitors,HIV-1 viral load,and development of drug resistance in an indigent population显示文摘 | Bangsberg DR Hecht FM Charlebois ED | 2000 | AIDS2000，14，： | 1 |
| 12 | Non-adherenceto highly active antiretroviral therapy predicts progression to AIDS显示文摘 | Bangsberg DR Perry S Chalebois ED | 2001 | AIDS2001，15，9： | 1 |
| 13 | Preventing HIV antiretroviral resistance through better monitoring of treatment adherence 显示文摘 | Bangsberg DR | 2008 | J Infect Dis2008，197，3： | 1 |
| 14 | Internalized stigma, social distance,and disclosure of HIV seropositivity in Rural Uganda显示文摘 | Tsai AC Bangsberg DR Kegeles SM | 2013 | Ann Behav Med2013，46，3： | 1 |
| 15 | Preventing HIV antiretroviral resistance throughbetter monitoring of treatment adherence显示文摘 | Bangsberg DR | 2008 | J Infect Dis2008，197，3： | 1 |
| 16 | Adherence toHAART:A systematic review of developed and developing na-tion patient-reported barriers and facilitators显示文摘 | Mills EJ Nachega JB Bangsberg DR | 2006 | PLOS Med2006，3，11： | 1 |
| 17 | Non-adherence to highly active antiretroviral therapy predicts progression to AIDS显示文摘 | Bangsberg DR Perry S Charlebois ED | 2001 | AIDS2001，15，9： | 1 |
| 18 | The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco显示文摘 | Hermanstyne K Bangsberg DR Hennessey K | | 0，，： | 1 |
| 19 | Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART显示文摘 | Hogg RS Bangsberg DR Lima VD | 2006 | Plos Med2006，3，9： | 1 |
| 20 | Non-adherence to highly active antiretroviral therapy predicts progression to AIDS显示文摘 | Bangsberg DR Perry S Charlebois ED | 2001 | AIDS2001，15，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员